Insider · CIK 0001423029

Anzalone Christopher Richard

Reports to the SEC for 1 company · PASADENA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001423029

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-02	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−7,416 sh	$65.88	−$489K	3,798,510
2026-01-02	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−5,771 sh	$66.39	−$383K	3,792,739
2025-12-29	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−16.5K sh	$68.69	−$1.14M	3,805,926
2025-12-29	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+35.2K sh	$6.15	+$216K	3,841,107
2025-12-29	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy Common Stock)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−35.2K sh	—	—	16,545
2025-12-29	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−35.2K sh	$69.33	−$2.44M	3,822,471
2025-12-29	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+16.5K sh	$6.15	+$102K	3,857,652
2025-12-29	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy Common Stock)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−16.5K sh	—	—	0
2025-12-22	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−2,574 sh	$68.85	−$177K	3,805,926
2025-12-22	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−10K sh	$68.33	−$684K	3,808,500
2025-12-19	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−8,147 sh	$68.01	−$554K	3,819,831
2025-12-19	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−1,319 sh	$68.48	−$90.3K	3,818,512
2025-12-19	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−3,979 sh	$66.67	−$265K	3,827,978
2025-12-17	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−35.8K sh	$64.51	−$2.31M	3,834,920
2025-12-17	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−1,981 sh	$66.30	−$131K	3,831,957
2025-12-17	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−46.3K sh	$63.55	−$2.94M	3,870,670
2025-12-17	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−982 sh	$65.53	−$64.4K	3,833,938
2025-12-16	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−1,000 sh	$64.96	−$65K	3,921,644
2025-12-16	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−11K sh	$61.25	−$671K	3,951,876
2025-12-16	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−8,476 sh	$62.94	−$533K	3,929,305
2025-12-16	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−6,661 sh	$64.29	−$428K	3,922,644
2025-12-16	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−3,221 sh	$67.87	−$219K	3,916,957
2025-12-16	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−8,416 sh	$60.51	−$509K	3,962,839
2025-12-16	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−14.1K sh	$62.12	−$876K	3,937,781
2025-12-16	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−166 sh	$66.77	−$11.1K	3,920,178
2025-12-16	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−1,300 sh	$65.77	−$85.5K	3,920,344
2025-12-15	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−21.3K sh	$69.28	−$1.48M	3,979,402
2025-12-15	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−101K sh	$68.67	−$6.9M	4,000,723
2025-12-15	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−8,147 sh	$69.96	−$570K	3,971,255
2025-12-12	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer	AAward	+180K sh	—	—	4,101,255
2025-04-11	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−50.8K sh	$11.49	−$584K	3,921,255
2025-04-10	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−50K sh	$10.87	−$544K	3,972,055
2025-04-09	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−35.3K sh	$9.93	−$351K	4,027,072
2025-04-09	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−3,400 sh	$10.75	−$36.6K	4,023,672
2025-04-09	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−1,617 sh	$11.76	−$19K	4,022,055
2025-03-13	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−51.4K sh	$15.07	−$775K	4,062,377
2025-03-13	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer	AAward	+340K sh	—	—	4,113,802
2025-03-04	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−133K sh	$17.02	−$2.27M	3,773,802
2025-03-04	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+133K sh	$7.75	+$1.03M	4,073,802
2025-03-03	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy Common Stock)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−133K sh	—	—	51,726
2025-03-03	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy Common Stock)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−167K sh	—	—	185,059
2025-03-03	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+167K sh	$7.75	+$1.29M	3,940,469
2025-03-03	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−167K sh	$18.03	−$3.01M	3,907,135
2025-02-07	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer	AAward	+9,550 sh	$20.10	+$192K	3,773,802
2025-01-02	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−11.5K sh	$19.05	−$219K	3,764,252
2024-12-23	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−12.6K sh	$19.59	−$246K	3,775,772
2024-12-18	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	3,788,335
2024-12-18	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−5,799 sh	$22.12	−$128K	3,688,335
2024-12-18	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−8,260 sh	$21.74	−$180K	3,694,134
2024-12-18	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−12.7K sh	$20.52	−$260K	3,702,394

Recent filings

Accepted (ET)
Jan 54
Anzalone Christopher Richard0001423029-26-000001
SEC(opens sec.gov)
Dec 304
Anzalone Christopher Richard0001423029-25-000009
SEC(opens sec.gov)
Dec 234
Anzalone Christopher Richard0001423029-25-000007
SEC(opens sec.gov)
Dec 194
Anzalone Christopher Richard0001423029-25-000005
SEC(opens sec.gov)
Dec 164
Anzalone Christopher Richard0001423029-25-000003
SEC(opens sec.gov)

Companies

ARROWHEAD PHARMACEUTICALS, INC.Director, Chief Executive OfficerARWR

Address

201 SOUTH LAKE AVENUE SUITE 703

PASADENA, CA, 91101